Stopping semaglutide: what actually happens and what to consider first

You've reached your goal, and now you're wondering whether you still need it

This is the moment many people reach and feel uncertain about. You have lost the weight, you feel well, and the weekly injection starts to feel unnecessary. It is a completely reasonable place to be. The misconception worth letting go gently here is that semaglutide has somehow reset your body for good. It has not, and there is no shame in that. What it has done is reduce appetite signalling via GLP-1 receptors while it is active in your system. Once you stop, those signals gradually return to their pre-treatment pattern.

Research published after the STEP 1 trial (which tracked semaglutide 2.4mg over 68 weeks) followed participants for a year after stopping. On average, about two-thirds of the weight lost was regained within 12 months of discontinuation. You can read the NHS's overview of how semaglutide works and what stopping it involves for a patient-level summary. That figure does not mean stopping is the wrong choice; it means the decision deserves proper planning rather than simply running out of pens and not reordering.

The timeline matters too. Semaglutide has a half-life of roughly one week, so the medicine takes several weeks to clear fully. Hunger tends to increase gradually rather than overnight, which gives a short window to notice the change and respond, adjusting food habits, activity, or both.

What the return of appetite actually feels like, and why it catches people off guard

People who have been on semaglutide for months often forget what their original hunger felt like. That is not dramatic; it is just how effective appetite suppression works. When the medicine fades, the return can feel disproportionate simply because the baseline has shifted in memory. Food noise (the persistent background thoughts about eating that many patients describe reducing significantly on treatment) tends to come back.

This is why how you stop matters as much as when you stop. Stopping from a lower maintenance dose may produce a gentler transition than stopping from 2.4mg abruptly, though the evidence on tapering is not yet definitive. What is clearer is that the lifestyle habits built during treatment (portion awareness, protein adequacy, regular activity) are the main buffer against rapid regain. Patients who have made those changes genuine and habitual tend to fare better after stopping than those who relied primarily on the pharmacological effect.

There are also circumstances where stopping is the clinician's recommendation rather than the patient's preference: pregnancy, certain planned surgical procedures, or the development of a contraindication. In those cases the question shifts from "should I stop" to "how do I manage the transition."

Deciding when stopping is the right call, and what that process looks like at a regulated pharmacy

NICE guidance on semaglutide for weight management specifies a maximum recommended duration of two years within an NHS specialist setting, but private prescribing does not carry a hard time limit in the same way. Duration is a clinical judgement. The relevant questions your prescriber will weigh are: how much weight-related health risk remains, how stable your weight has been at your current dose, whether the lifestyle changes are genuinely embedded, and what your own goals are.

At nume, every repeat order is reviewed by a GPhC-registered prescriber before it is dispensed, there is no automatic renewal. That means the question of whether to continue is raised regularly, not just when you decide to raise it. If you are thinking about stopping, our prescribers are a straightforward resource; you can get in touch with our aftercare team seven days a week. For a broader look at what treatment involves from the start, the Wegovy overview page gives the fuller picture.

For people who have achieved their goal weight and are weighing up whether continuing is justified, it is worth reading about stopping semaglutide specifically after reaching a weight-loss target, the considerations there are slightly different from stopping mid-treatment. And if timing is the main question rather than whether to stop at all, there is specific guidance on when stopping Wegovy is clinically appropriate.

What about pausing rather than stopping entirely?

A short break is not the same as stopping. If you are asking how semaglutide can be paused (whether for travel, a planned procedure, or a short-term reason) the pharmacological effect does begin to reduce within days of a missed dose, though a week's gap is unlikely to undo months of progress. There is a separate, more detailed answer to whether pausing Wegovy for a week is safe and what to expect when you restart.

What is worth knowing is that restarting after a break typically means returning to an earlier dose and re-titrating, since tolerance to GI side effects reduces during a gap. This is something to plan in advance rather than discover mid-restart. Cost is sometimes a factor in pause decisions too, if that is part of what you are weighing up, the Wegovy cost context page sets out what a full private treatment cycle typically involves financially.

The short version: stopping semaglutide is always your choice, it is medically safe, and the main consideration is weight regain and how prepared you are to manage it. Talk to your prescriber before you do. If you are not yet on treatment but thinking through whether semaglutide is right for you, a free consultation with our prescribers is the place to start.